•The BL1332 study did not meet its primary endpoint for pain relief over 24 hours; the mean difference was -11.5 at the 0.30% concentration and -9.0 at 0.15%.
•The Phase 2 trial included 129 adults, assigned in a 2:2:1 ratio to the two BL1332 concentrations and vehicle.
•Complete pain resolution after 6 hours was reported by 14.0% with the 0.30% concentration and 14.6% with 0.15%, compared with 3.7% with placebo.
•An EL7 headline on November 19 reported that Citigroup understated risk-weighted assets by $35 billion because of recording errors.
•Citi’s risk-weighted assets were $1,232,261 million under the standardized approach and $1,312,128 million under the advanced approach on September 30, 2026.
•The Common Equity Tier 1 capital ratio was 12.8%, about 120 basis points above the 11.6% regulatory minimum on September 30, 2026.
•The committee disclosed applications to sell 3.4 million AI chips to China and approval for more than 879,000.
•The approvals included exports to Alibaba and Tencent, which the committee's statement described as designated Chinese military companies under the Department of War.
•Licensed H200 shipments accounted for less than 1% of data center revenue in the latest quarter at the time of the disclosure.
•Ukrainian agricultural product exports reached 2.17 million metric tons in September 2026, compared with 5.19 million metric tons in May 2026.
•Estimates for Ukrainian crop exports in the 2026/27 season were cut again because of the deteriorating security situation in the Black Sea and attacks on domestic logistics.
•Ukraine’s prime minister expected grain and oilseed production to exceed 80 million tonnes in 2026.